To achieve the estimated 75%-80% vaccination rate needed for herd immunity, the nation will need to invest in reaching virtually all adults in the United States. This daunting task requires thinking about communities at risk for poor health outcomes, particularly communities of color.
By delivering free naloxone and other harm reduction supplies discreetly and confidentially to people’s homes, what arrives in the mail could save a life. That’s the take-home message from an innovative approach to reducing opioid overdose deaths in Philadelphia, where the fatal overdose rate surpasses that of other large U.S. cities.
In the past few months, we have seen what can be accomplished when the federal government marshalls its resources and mobilizes a nation to address a health crisis. While there is no vaccine for the epidemic of overdoses that has claimed more than 80,000 lives in the past year alone, we already have effective treatments for opioid use disorders and proven life-saving strategies. There is an urgent need for federal leadership to address an overdose crisis that has worsened throughout the pandemic.
As the remaining non-expansion states consider expanding Medicaid eligibility, a new study offers encouraging evidence that Medicaid patients’ access to surgical care can be maintained even when enrollment surges.
[Cross-posted from the Tradeoffs Research Corner]
[Cross-posted with Penn Center for Mental Health]